Obesity drugs: huge study identifies new health risks
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis Risk assessment The study focused on GLP-1 receptor agonists, including semaglutide, which is sold as Ozempic to treat diabetes and is now widely prescribed for weight loss. “No one had comprehensively investigated the effectiveness and risks of GLP-1 receptor agonists […]
Obesity drugs: huge study identifies new health risks Read More »